Evaluation of Stability of Thiopurine Metabolites Using a Validated LC-MS/MS Method
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Measurement of thiopurine metabolites is helpful to monitor adverse effects and assess compliance in patients on thiopurine treatment. The purpose of this study was to develop and validate an analytical method for measurement of thiopurine metabolites, thioguanine nucleotides (6-TGN) and 6-methylmercaptopurine nucleotide (6-MMPN), in RBCs. We developed and validated a liquid chromatography–tandem mass spectrometry (LC-MS/ MS) method for the quantification of 6-TGN and 6-MMPN and evaluated the stability of the thiopurine metabolites in RBC and whole blood states without any preprocessing at various storage conditions. The linear range was 0.1–10 μmol/L and 0.5–100 μmol/L for 6-TGN and 6-MMPN, respectively. The mean extraction recovery at the two concentrations was 71.0% and 75.0% for 6-TGN, and 102.2% and 96.4% for 6-MMPN. Thiopurine metabolites in preprocessed RBC samples were stable at 25°C and 4°C after storage for 4 hours and at –70°C for up to 6 months. However, 6-TGN decreased by 30% compared with the initial concentration when stored at –20°C for 180 days. In whole blood states, 6-TGN decreased by about 20% at four days after storage at 4°C. We validated a reliable LC-MS/MS method and recommend that the patient’s whole blood sample be preprocessed as soon as possible.
Abstract
Measurement of thiopurine metabolites is helpful to monitor adverse effects and assess compliance in patients on thiopurine treatment. The purpose of this study was to develop and validate an analytical method for measurement of thiopurine metabolites, thioguanine nucleotides (6-TGN) and 6-methylmercaptopurine nucleotide (6-MMPN), in RBCs. We developed and validated a liquid chromatography–tandem mass spectrometry (LC-MS/ MS) method for the quantification of 6-TGN and 6-MMPN and evaluated the stability of the thiopurine metabolites in RBC and whole blood states without any preprocessing at various storage conditions. The linear range was 0.1–10 μmol/L and 0.5–100 μmol/L for 6-TGN and 6-MMPN, respectively. The mean extraction recovery at the two concentrations was 71.0% and 75.0% for 6-TGN, and 102.2% and 96.4% for 6-MMPN. Thiopurine metabolites in preprocessed RBC samples were stable at 25°C and 4°C after storage for 4 hours and at –70°C for up to 6 months. However, 6-TGN decreased by 30% compared with the initial concentration when stored at –20°C for 180 days. In whole blood states, 6-TGN decreased by about 20% at four days after storage at 4°C. We validated a reliable LC-MS/MS method and recommend that the patient’s whole blood sample be preprocessed as soon as possible.
참고문헌 (15)
- Karran P, "Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer", Nat Rev Cancer, 8, pp.24~36 (2008)[DOI]
- Sahasranaman S, "Clinical pharmacology and pharmacogenetics of thiopurines", Eur J Clin Pharmacol, 64, pp.753~767 (2008)[DOI]
- Gearry RB, "Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease", J Gastroenterol Hepatol, 20, pp.1149~1157 (2005)[DOI]
- Lee MN, "Impact of genetic polymorphisms on 6-thioguanine nucleotide levels and toxicity in pediatric patients with IBD treated with azathioprine", Inflamm Bowel Dis, 21, pp.2897~2908 (2015)[DOI]
- Dervieux T, "Simultaneous determination of 6-thioguanine and methyl 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC", Clin Chem, 44, pp.551~555 (1998)
- Vikingsson S, "Monitoring of thiopurine metabolites - a high-performance liquid chromatography method for clinical use", J Pharm Biomed Anal, 75, pp.145~152 (2013)[DOI]
- Nygaard U, "Methylated metabolites of 6-mercaptopurine are associated with hepatotoxicity", Clin Pharmacol Ther, 75, pp.274~281 (2004)[DOI]
- Dubinsky MC, "6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease", Gastroenterology, 122, pp.904~915 (2002)[DOI]
- Cuffari C, "Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease", Clin Gastroenterol Hepatol, 2, pp.410~417 (2004)[DOI]
- Dervieux T, "Liquid chromatography-tandem mass spectrometry analysis of erythrocyte thiopurine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathioprine", 6-mercaptopurine therapy, 2005, pp.51, 2074~2084
- Cangemi G, "A validated HPLC method for the monitoring of thiopurine metabolites in whole blood in paediatric patients with inflammatory bowel disease", Int J Immunopathol Pharmacol, 25, pp.435~444 (2012)[DOI]
- Neurath MF, "6-thioguanosine diphosphate and triphosphate levels in red blood cells and response to azathioprine therapy in Crohn's disease", Clin Gastroenterol Hepatol, 3, pp.1007~1014 (2005)[DOI]
- de Graaf P, "Stability of thiopurine metabolites: a potential analytical bias", Clin Chem, 54, pp.216~218 (2008)
- Pike MG, "Improved methods for determining the concentration of 6-thioguanine nucleotides and 6-methylmercaptopurine nucleotides in blood", J Chromatogr B Biomed Sci Appl, 757, pp.1~9 (2001)[DOI]
- Kirchherr H, "Improved method for therapeutic drug monitoring of 6-thioguanine nucleotides and 6-methylmercaptopurine in whole-blood by LC", MSMS using isotope-labeled internal standards, 2013, pp.35, 313~321